CC-5013 in Treating Patients With Cancer That Has Not Responded to Previous Therapy
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
RATIONALE: CC-5013 may stop the growth of cancer by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of CC-5013 in treating patients who have solid tumors and/or lymphoma that did not respond to previous therapy.
创建时间：
2002-04-15
